This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1994 Apr 9;343(8902):867-8.

doi: 10.1016/s0140-6736(94)90003-5.

Anticoagulation: how low can one go?

F R Rosendaal¹

Affiliations

PMID: 7908353
DOI: 10.1016/s0140-6736(94)90003-5

Comment

Anticoagulation: how low can one go?

F R Rosendaal. Lancet. 1994.

. 1994 Apr 9;343(8902):867-8.

doi: 10.1016/s0140-6736(94)90003-5.

Author

F R Rosendaal¹

Affiliation

¹ Department of Clinical Epidemiology, Leiden University Hospital, Netherlands.

PMID: 7908353
DOI: 10.1016/s0140-6736(94)90003-5

No abstract available

PubMed Disclaimer

Comment on

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer.
Levine M, Hirsh J, Gent M, Arnold A, Warr D, Falanga A, Samosh M, Bramwell V, Pritchard KI, Stewart D, et al. Levine M, et al. Lancet. 1994 Apr 9;343(8902):886-9. doi: 10.1016/s0140-6736(94)90008-6. Lancet. 1994. PMID: 7908358 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information